Therapeutic Efficacy of Mesenchymal Stem Cells in Modulating Oxidative Stress in Puromycin-Induced Nephropathy

<b><i>Background:</i></b> Podocytes are essential for kidney function, and their dysfunction can result in nephrotic syndrome, such as minimal change disease (MCD). Oxidative stress contributes to podocyte damage. We investigated the therapeutic potential of intravenously infused mesenchymal stem ce...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yusuke Iizuka, Masanori Sasaki, Kojiro Terada, Takuro Sakai, Yoshinobu Nagaoka, Shinobu Fukumura, Jeffery D. Kocsis, Takeshi Tsugawa, Osamu Honmou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-05-01
Colecção:	Pathophysiology
Assuntos:	intravenous mesenchymal stem cell minimal change disease puromycin aminonucleoside
Acesso em linha:	https://www.mdpi.com/1873-149X/32/2/19
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!